A股異動 | 樂心醫療(300562.SZ)漲5.37% 醫用電子血壓計獲得醫療器械註冊證
格隆匯2月22日丨樂心醫療(300562.SZ)漲5.37% ,報13.15元,總市值19億元。該公司上週五公佈,公司於近日收到廣東省藥品監督管理局下發的《中華人民共和國醫療器械註冊證》,產品名稱為醫用電子血壓計,適用於以示波法測量人體(成人及三歲以上兒童)的血壓和脈率,其數值供臨牀參考。本款2000-C醫用電子血壓計由主機、D形環袖帶及適配器(選配)組成,採用示波法測量人體(成人及三歲以上兒童)的血壓和脈率,測量的數據通過液晶顯示屏顯示並可通過低功耗藍牙通信上傳至指定的APP軟件,其數值供臨牀參考。該款產品對公司加快建立和完善慢病管理領域健康IoT及遠程健康管理整體解決方案起到積極作用。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.